Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF) has officially resumed trading on the OTCQB Venture Market in the United States as of August 5, 2025. This marks a pivotal moment for the company as it aims to expand its footprint and investor base within the U.S. market.
The company's return to trading is considered part of its broader strategy to enhance visibility in global capital markets. With this development, Organto is looking towards the possibility of an uplisting to the OTCQX, the highest tier within the OTC Markets, as its business continues to evolve and meet the requisite qualifications.
Organto's shares are also eligible for electronic clearing and settlement through the Depository Trust Company (DTC), facilitating easier transactions for investors. The DTC's involvement is critical, as it ensures that Organto’s shares are part of a well-regulated trading environment, enhancing attractiveness for potential investors.
Steve Bromley, CEO and Co-Chair of Organto Foods Inc., stated that the resumption of trading reflects the ongoing efforts to realign and restructure the business over the past 20 months. He expressed optimism about building a world-class company in the healthy foods sector, emphasizing the commitment to create lasting value for all stakeholders.
The OTCQB is recognized for its rigorous standards, requiring companies to adhere to best practices in corporate governance and compliance with U.S. securities laws. This regulatory framework helps build trust and provides necessary transparency for investors analyzing potential opportunities in Organto's shares.
The return to trading on the OTCQB Venture Market indicates a significant advancement in Organto's strategic goals and enhances its visibility within the U.S. markets. This move is likely to attract a broader investment base as the company continues its focus on growth in the health food sector.
Trading on the OTCQB is expected to expand Organto's investor base significantly, allowing access to a larger pool of U.S. investors. This increased exposure can bolster liquidity and investor interest, presenting a solid opportunity for further business development.
Organto has expressed intentions to uplist to the OTCQX as it meets necessary qualifications. Such a move would signify a further commitment to compliance and governance, potentially benefiting the company’s market perception and investor confidence.
The OTCQB provides a well-regulated marketplace that meets high financial standards and corporate governance best practices. This environment can enhance Organto's visibility and trustworthiness among investors, facilitating better trading conditions.
Being eligible for electronic clearing and settlement through the DTC streamlines the trading process for Organto's shares. This typically increases efficiency and can enhance liquidity, making it more attractive for potential investors.
Organto is committed to developing a world-class presence in the fast-growing healthy foods market, leveraging a strategic asset-light business model that prioritises sustainability. This focus aligns with increasing consumer demand for health-conscious products, positioning Organto favourably for future growth.
Organto's long-term vision includes creating lasting value for its stakeholders while ensuring sustained growth and profitability. The initiatives developed during the past 20 months reflect a clear path towards achieving these strategic goals.
As with any investment, prospective investors should consider market volatility, regulatory risks, and the potential for unforeseen delays. While these risks exist, Organto’s commitment to restructuring and growth may mitigate some uncertainty and foster confidence in its long-term success.